Glenn Goddard - EVP, Chief Financial Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Financial Officer
Stock Symbol
NTLA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

Glenn Goddard - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by Glenn Goddard for Intellia Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 69.2K $2.03M $29.38 Mar 1, 2024 Direct
Restricted Stock Unit 3.06K $73.2K $23.90 Jan 1, 2024 Direct Common Stock
Stock Option (right to buy) 41.3K Mar 1, 2024 Direct Common Stock

Transactions reported by Glenn Goddard for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.